Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Temporarily not available × Gemcitabine × 1 year × Clear all

Status

Recruiting 197 Active not recruiting 137 Completed 76 Not yet recruiting 48 Terminated 28 Withdrawn 3 Temporarily not available 2 Suspended 2

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Locally Advanced Pancreatic Adenocarcinoma 1 KRAS G12V Mutant Advanced Epithelial Cancers 1

Interventions

Gemcitabine 2 pembrolizumab 1 Taxes 1 Insulin Infusion Systems 1 FANG vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07319910 2026-01-06

PANOVA-3CA

NovoCure Ltd.

Temporarily not available

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡